Raymond Wall
Family Medicine · Oklahoma City, OKNPI 1710921291
Payments from drug & device makers
Across 306 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$866
- Lilly USA, LLC$727
- Novo Nordisk$479
- Pfizer$463
- Amgen$380
- AstraZeneca$255
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,857100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 67 | $866 |
| Lilly USA, LLC | 47 | $727 |
| Novo Nordisk | 27 | $479 |
| Pfizer | 28 | $463 |
| Amgen | 25 | $380 |
| AstraZeneca | 17 | $255 |
| Boehringer Ingelheim | 7 | $133 |
| Otsuka America Pharmaceutical, Inc. | 6 | $124 |
| Antares Pharma, Inc. | 5 | $115 |
| Astellas Pharma US Inc | 6 | $113 |
| GSK | 7 | $110 |
| Esperion Therapeutics, Inc. | 6 | $108 |
| Biohaven Pharmaceuticals, Inc. | 6 | $94 |
| Merck | 6 | $94 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $92 |
| Currax Pharmaceuticals LLC | 4 | $54 |
| Therapeuticsmd, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Exact Sciences | 3 | $48 |
| Novartis | 2 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Halozyme Inc | 2 | $38 |
| Bayer | 2 | $38 |
| Abbott | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Johnson & Johnson | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Vistapharm, Inc. | 1 | $15 |
| Biogen | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Boston Scientific | 1 | $13 |
How this compares
$4,863 in reported general payments places this provider in the 85th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $71,947 |
| EliquisApixaban | 40 | $44,439 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $15,494 |
| JanuviaSitagliptin Phosphate | 25 | $13,892 |
| Repatha SureclickEvolocumab | 12 | $11,733 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 230 | $5,501 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $5,260 |
| Fentanyl | 16 | $4,615 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $4,234 |
| Atorvastatin Calcium | 156 | $2,286 |
| Pregabalin | 32 | $2,250 |
| Gabapentin | 61 | $2,036 |
| Testosterone | 27 | $1,956 |
| Nebivolol Hcl | 24 | $1,645 |
| Levothyroxine Sodium | 166 | $1,625 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $479 | $71,94757 claims |
| PfizerEliquis, Paxlovid | $463 | $45,86854 claims |
| GSKTrelegy Ellipta | $110 | $15,49420 claims |
| MerckJanuvia | $94 | $13,89225 claims |
| AstraZenecaSymbicort | $255 | $4,23414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Oklahoma City
- Carl GriffinOklahoma City$28.2M
- Alexander FrankOklahoma City$3.1M
- Charles LunnOklahoma City$1.4M
- Hieu NguyenOklahoma City$238K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Brett CauthenOklahoma City$77K
- Angelique BarretoOklahoma City$74K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.